| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -9.86 M USD | -9.37 M USD | -9.76 M USD | -9.65 M USD | -6.68 M USD |
| Depreciation & Amortization | 150000 USD | 171000 USD | 111000 USD | 54000 USD | 25000 USD |
| Stock-Based Compensation | 3.58 M USD | 1.89 M USD | 1.43 M USD | 4.88 M USD | 6.70 M USD |
| Capital Expenditures | 103000 USD | 164000 USD | 206000 USD | 263000 USD | 182000 USD |
| Cash Flow from Investing | 565000 USD | 1.49 M USD | 4.59 M USD | -7.38 M USD | -182000 USD |
| Cash Flow from Financing | 7.33 M USD | 7.90 M USD | 3.45 M USD | — | 30.20 M USD |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — |
| Free Cash Flow | -9.96 M USD | -9.54 M USD | -9.96 M USD | -9.91 M USD | -6.87 M USD |
Qtrex Quantum Ltd. is a specialty medical device company focused on developing, manufacturing, and marketing advanced technologies for critical care and respiratory support. Its product portfolio centers on innovative systems designed to improve patient treatment in hospital settings, with an emphasis on oxygenation and life-support-related applications. The company serves healthcare providers that require specialized equipment for intensive care, emergency medicine, and other high-acuity environments. Qtrex Quantum Ltd. operates at the intersection of medical technology and clinical support, where its products are intended to address complex patient management needs and support physicians in demanding care situations. Through its research, engineering, and commercialization activities, the company plays a role in the broader medical device market by supplying solutions for institutions seeking specialized respiratory and therapeutic technologies.